BioWorld

May 14, 2004

View Archived Issues

Genta Slashes Work Force To Curb Spending, Conserve Cash

Ten days after an FDA panel voted against Genta Inc.'s lead drug candidate, the company laid off nearly half its work force in an effort to conserve cash. (BioWorld Today) Read More

Dyax, Syntonix Enter Antibody Drug Development Agreement

Read More

Ensemble Discovery Series A Gets $15M For 'Pioneer' Work

Read More

As Investor Interest Grows, Northfield Raising $23.4M

Read More

Other News To Note

Read More